GlassScriptPhysician profile
Brian F Pontarelli
NPI 1194804831
$14,538.27
in general payments reported to CMS, 2019-2025
42 companies · $901 in 2025
The $901 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,927 · 2020: $1,137 · 2021: $3,423 · 2022: $3,096 · 2023: $1,965 · 2024: $2,089 · 2025: $901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,955.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $6,425.25 | 2021-2024 | |
| Smith+Nephew, INC. | $2,067.99 | 2019-2025 | Stravix, Collagenase Santyl, Iodosorb Ointment 40g USA |
| Paratek Pharmaceuticals, INC. | $822.64 | 2020-2025 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $738.98 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $471.84 | 2019-2023 | Tapestry, Nextremity General Instrument, Accufill |
| Stryker Corporation | $414.37 | 2020-2025 | Prostep, Prophecy, Phalinx |
| Orthofix Medical, INC. | $376.06 | 2022-2025 | Physio-Stim |
| Acell, INC. | $339.99 | 2019-2020 | |
| Treace Medical Concepts, INC. | $338.62 | 2022-2025 | |
| Kerecis Limited | $296.37 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $250.23 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Horizon Therapeutics Plc | $195.67 | 2019-2021 | |
| Wright Medical Technology, INC. | $192.02 | 2019 | |
| Medtronic, INC. | $181.41 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $163.09 | 2019-2021 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $160.92 | 2020-2023 | |
| Arthrex, INC. | $111.84 | 2019 | |
| Amniox Medical, INC. | $98.33 | 2019 | |
| Medtronic Vascular, INC. | $92.64 | 2019 | |
| Ibsa Pharma INC. | $63.93 | 2022-2023 | Tirosint, Licart |
| Sebela Pharmaceuticals INC. | $62.97 | 2021-2023 | Naftin |
| Misonix INC | $60.44 | 2021 | |
| Kairos Surgical INC | $57.27 | 2023 | |
| Kuros Biosciences USA, INC | $50.72 | 2023 | |
| Organogenesis INC. | $48.54 | 2020-2023 | Puraply |
| Bioventus LLC | $46.53 | 2019 | |
| Ani Pharmaceuticals, INC. | $45.28 | 2025 | Purified Cortrophin Gel |
| Nevro Corp. | $40.77 | 2022 | |
| Pfizer INC. | $37.61 | 2019-2020 | |
| Acumed LLC | $36.78 | 2020 | |
| Lifenet Health | $28.52 | 2024 | Theragenesis Wound Matrix |
| Kci USA, INC. | $27.54 | 2019 | |
| Medline Industries LP | $26.46 | 2019-2020 | |
| In2bones USA, LLC | $24.74 | 2019 | |
| Abbvie INC. | $23.82 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.17 | 2022 | |
| Derma Sciences, INC. | $19.27 | 2019 | |
| Merz North America, INC. | $17.05 | 2024 | |
| Convatec INC. | $16.82 | 2023 | |
| Baudax Bio INC. | $16.51 | 2022 | |
| Dynasplint Systems INC. | $14.14 | 2019 | |
| Nabriva Therapeutics, Plc | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Pontarelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.